Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Claris Lifesciences Ltd Board approves buy-back of equity shares and declares interim dividend


Tuesday, 7 Jan 2014 03:55am EST 

Claris Lifesciences Ltd:Says Board has approved the buyback of upto 92,50,000 (9,250,000) equity shares of the company of the face value of 10 Indian Rupee each at a price of 250 Indian Rupee per equity share aggregating to 2,31,25,00,000 Indian Rupee (2,312,500,000 bln Indian Rupee ) through the tender offer route.Says it is representing 14.49 pct of the total number of the equity share capital.Says the Board has declared interim dividend of 9 Indian Rupee per equity share of 10 Indian Rupee each of the company.Says Board has decided that, the interim dividend will be paid/dispatched to the equity shareholders on Feb. 04.Says it has fixed Jan. 21, 2014 as record date for the purpose of payment of interim dividend. 

Company Quote

175.3
-6.0 -3.31%
6:28am EDT